抄録
Mycobacterium tuberculosis, the causative agent of tuberculosis, possess flavin-dependent thymidylate synthase, ThyX. Since thyX is absent in humans and was shown to be essential for M. tuberculosis normal growth, ThyX is thought to be an attractive novel TB drug target. This study assessed thyX essentiality in Mycobacterium bovis BCG strains using CRISPR interference based gene silencing and found that thyX is not essential in an M. bovis BCG Tokyo derivative strain. A thyX deletion mutant strain was successfully constructed from that strain, which reinforces the non-essentiality of thyX under a certain genetic background.
| 本文言語 | English |
|---|---|
| ページ(範囲) | 10-14 |
| ページ数 | 5 |
| ジャーナル | MICROBIOLOGY and IMMUNOLOGY |
| 巻 | 66 |
| 号 | 1 |
| DOI | |
| 出版ステータス | Published - 1月 2022 |
UN SDG
この成果は、次の持続可能な開発目標に貢献しています
-
SDG 3 すべての人に健康と福祉を
ASJC Scopus subject areas
- 微生物学
- 免疫学
- ウイルス学
フィンガープリント
「Attempt of thyX gene silencing and construction of a thyX deleted clone in a Mycobacterium bovis BCG」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。引用スタイル
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS